A possible role of vimentin on the cell surface for the activation of latent transforming growth factor-β

被引:8
|
作者
Nishida, Yasutake [1 ]
Shibata, Kenji [1 ]
Yamasaki, Motoo [1 ]
Sato, Yasufumi [2 ]
Abe, Mayumi [2 ]
机构
[1] Kyowa Hakko Kirin Co Ltd, Div Res, Innovat Drug Res Labs, Tokyo 1948533, Japan
[2] Tohoku Univ, Inst Dev Aging & Canc, Dept Vasc Biol, Sendai, Miyagi 9808575, Japan
关键词
Latent TGF-beta activation; Vimentin; LAP fragment; Avidin-biotin affinity; Proteolysis; SMOOTH-MUSCLE-CELLS; TGF-BETA; SYNOVIAL-FLUID; BINDING;
D O I
10.1016/j.febslet.2008.12.051
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Latent TGF-beta (LTGF-beta) has to be converted to active TGF-beta for its activities. Previously, we reported that certain fragments of latency associated peptide (LAP) augmented LTGF-beta activation via increase in binding of LTGF-beta to the endothelial cell (EC) surface followed by cell-associated proteolysis. By searching for EC membrane proteins crosslinked with the LAP fragment, we identified the molecule bound to LAP fragment as vimentin. Moreover, the LAP fragment-induced LTGF-beta activation was attenuated by anti-vimentin antibody. These results indicate that binding of the LAP fragment to vimentin on the cell surface is indispensable for LTGF-beta activation by the LAP fragment.
引用
收藏
页码:308 / 312
页数:5
相关论文
共 50 条
  • [31] Monocytes may regulate tissue fibrosis -: Role of reactive oxygen species in monocyte survival and in the activation of latent transforming growth factor-β
    Marsh, CB
    Kelley, TW
    Graham, MM
    Dong, CM
    Goldschmidt-Clermont, PJ
    CHEST, 2001, 120 (01) : 15S - 16S
  • [32] Role of transforming growth factor-β2 in, and a possible Transforming Growth Factor-β2 gene polymorphism as a marker of, renal dysfunction in essential hypertension:: A study in Turkish patients
    Bicik, Z
    Gönen, S
    Bahçebasi, T
    Reis, K
    Arinsoy, T
    Sindel, S
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2005, 66 (04): : 266 - 278
  • [33] Activation and transforming growth factor-β production in eosinophils by hyaluronan
    Ohkawara, Y
    Tamura, G
    Iwasaki, T
    Tanaka, A
    Kikuchi, T
    Shirato, K
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2000, 23 (04) : 444 - 451
  • [34] Transforming Growth Factor-β Signaling Pathway Activation in Keratoconus
    Engler, Christoph
    Chakravarti, Shukti
    Doyle, Jefferson
    Eberhart, Charles G.
    Meng, Huan
    Stark, Walter J.
    Kelliher, Clare
    Jun, Albert S.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2011, 151 (05) : 752 - 759
  • [35] Transforming growth factor-β in T cell tolerance
    Li, MO
    Laouar, Y
    Peng, Y
    Gorelik, L
    Flavell, RA
    Autoimmune Liver Disease, 2005, 142 : 3 - 6
  • [36] Role of transforming growth factor-β1 and its latent form binding protein in pseudoexfoliation syndrome
    Schlötzer-Schrehardt, U
    Zenkel, M
    Küchle, M
    Sakai, LY
    Naumann, GOH
    EXPERIMENTAL EYE RESEARCH, 2001, 73 (06) : 765 - 780
  • [37] Possible involvement of transforming growth factor-β1 and transforming growth factor-β receptor type II during luteinization in the marmoset ovary
    Wehrenberg, U
    Giebel, J
    Rune, GM
    TISSUE & CELL, 1998, 30 (03): : 360 - 367
  • [38] Transforming growth factor-β and breast cancer -: Cell cycle arrest by transforming growth factor-β and its disruption in cancer
    Donovan, J
    Slingerland, J
    BREAST CANCER RESEARCH, 2000, 2 (02) : 116 - 124
  • [39] Transforming growth factor-β
    Unsicker, K
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (24): : 6953 - 6953
  • [40] Transforming growth factor-β and breast cancer: Cell cycle arrest by transforming growth factor-β and its disruption in cancer
    Jeffrey Donovan
    Joyce Slingerland
    Breast Cancer Research, 2